Revenue: The sum of all revenue fields included for a company's operating activities.
Bioxytran, Inc. (BIXT) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-0.52M |
|
-- |
|
-- |
|
$0.61M |
|
$-0.61M |
|
$0.08M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-0.61M |
|
$-0.60M |
|
91.84M |
|
91.84M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.51M |
|
-- |
|
$0.15M |
|
$0.66M |
|
$3.25M |
|
-- |
|
-- |
|
$3.25M |
|
$-2.63M |
|
$-2.74M |
|
$-2.59M |
|
108.15M |
|
| Cash Flow Statement Financials | |
$-0.53M |
|
$-0.02M |
|
$1.05M |
|
$0.01M |
|
$0.51M |
|
$0.50M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
-- |
|
-0.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
19.82% |
|
19.08% |
|
-79.29% |
|
20.15% |
|
$-0.02 |
|
$-0.01 |
|
$-0.01 |
|